Robin S Maurer, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 792 N Main St, Ste 200a, N Syracuse, NY 13212 Phone: 315-458-8700 Fax: 315-452-0411 |
Ms. Tina Lee Finlayson, RN, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5180 W Taft Rd, N Syracuse, NY 13212 Phone: 315-567-0437 Fax: 315-458-9629 |
Kayla Dussing, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5496 E Taft Rd, N Syracuse, NY 13212 Phone: 315-552-6700 Fax: 315-552-6701 |
Carol Scalzo, MSN FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 792 N Main St, N Syracuse, NY 13212 Phone: 315-440-9807 |
Kristen Ann Tyrrell, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 5180 W Taft Rd, N Syracuse, NY 13212 Phone: 315-458-4622 Fax: 315-458-9629 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Making healthy food easier to access in hospital canteens and food outlets, as well as increasing healthy options and reducing portion sizes, are the most effective ways of encouraging healthcare staff to improve their diets according to a new study from the University of Warwick.
Facing an urgent need for safer and more effective therapies for those suffering from debilitating pain in the midst of an opioid crisis, Saint Louis University researchers are on a mission to find a non-narcotic off-switch for pain.
Researchers at the University of Pennsylvania School of Medicine, in collaboration with scientists at the City University of New York, have identified a striking dysregulation in neuronal receptor activity in the postmortem brain tissue from patients with schizophrenia.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing five new Research Units.
› Verified 7 days ago